How has been the historical performance of Vaishali Pharma?

Answer:The historical performance of Vaishali Pharma shows significant fluctuations in its financial metrics over the years.

Breakdown:
Vaishali Pharma's net sales have shown a steady increase from INR 52.31 crore in March 2021 to INR 99.03 crore in March 2025, with a notable jump from INR 69.66 crore in March 2023 to INR 86.28 crore in March 2024. However, the total operating income peaked at INR 11.35 crore in March 2023 but dropped to INR 3.31 crore by March 2025. The operating profit margin, which was as high as 13.09% in March 2023, fell sharply to 0.1% in March 2025. Profit before tax also declined significantly from INR 8.85 crore in March 2023 to INR 1.23 crore in March 2025, while profit after tax decreased from INR 6.60 crore to INR 0.82 crore in the same period. The company's total assets increased from INR 66.08 crore in March 2020 to INR 109.66 crore in March 2025, reflecting growth in shareholder's funds, which rose to INR 64.92 crore. Despite this growth, total debt decreased from INR 14.72 crore in March 2020 to INR 8.50 crore in March 2025. Cash flow from operating activities has been negative in March 2025 at INR -18.00 crore, contrasting with positive cash flows in previous years. Overall, Vaishali Pharma's financial performance indicates a complex trajectory with growth in sales and assets but challenges in profitability and cash flow management.